Stock Events

Stock Events

Enliven Therapeutics (ELVN) Q4 2024 Earnings

13NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.55

-0.5

-0.46

-0.41

Details

Expected EPS

-0.496937

Actual EPS

-0.48

Surprise EPS

0.02

Surprise Percent

+3.41%

Description

Enliven Therapeutics (ELVN) has reported earnings of -0.48 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.